Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Politics

Conor McGregor Announces Presidential Bid Amid UFC Hiatus

Conor McGregor, one of the most famous fighters in UFC history, has recently shifted his focus from the octagon to…

Read More »
Economy

US Jobs Report Falls Short of Expectations for Second Consecutive Month

The highly-anticipated US jobs report, released today, showed the labor market continued cooling in August, as employers added just 142,000…

Read More »
Economy

Bank of Canada Cuts Rates for Third Time in a Row, Says Larger Rate Cuts Possible

The Bank of Canada (BoC) has once again lowered its key interest rate, marking the third consecutive cut in 2024,…

Read More »
Politics

NDP Ends Support Deal with Liberals in Major Canadian Political Shake-Up That Could Spark Snap Election

In a dramatic political shift, Canada’s New Democratic Party (NDP) has withdrawn its support for Prime Minister Justin Trudeau’s Liberal…

Read More »
Consumer

Temu Parent PDD Holdings Stock Plummets 28% Despite Strong Q2 Earnings Growth

PDD Holdings (NASDAQ: PDD) saw its stock decline 28% today, despite the parent company of popular e-commerce platforms Temu and…

Read More »
Healthcare

Therma Bright Adds New U.S. Nationwide Venowave Distribution Partner

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in a wide range of leading-edge, proprietary…

Read More »
Tech

All Systems Go: AST SpaceMobile (ASTS) Stock Throttles Up En Route to the Stars

AST SpaceMobile (NASDAQ: ASTS) stock continued its meteoric ascent today, as the trailblazing telecommunications company moves closer to potentially the most…

Read More »
Featured

Tiny Healthcare Stock With $35 Million Market Cap Becomes Major Player Overnight in Rapidly Growing $1 Billion Market

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a small healthcare stock and leader in proprietary diagnostic and medical device…

Read More »
Biotech

Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News

Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…

Read More »
Economy

Fed Eyes Rate Cut as US Inflation Hits Lowest Level Since 2021

US inflation has fallen to its lowest level since March 2021, opening the door for the Federal Reserve to consider…

Read More »
Back to top button